Clinical Trials on Thromboembolic Pathology

Total 235862 results

CHU de Reims

Completed

Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral Anticoagulants

Thromboembolic Event

France
Emory University
National Association of Orthopaedic Nurses

Completed

App Reminder on ASA Adherence

Thromboembolic Event

United States
University Hospital, Geneva

Completed

Pharmacogenetics of Acenocoumarol

Thromboembolic Diseases

Switzerland
Direction Centrale du Service de Santé des Armées

Recruiting

Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy (QuantiXa)

Venous Thromboembolic Disease

France
University Hospital, Strasbourg, France

Recruiting

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin (ENOX-VTD-H)

Venous Thromboembolic Disease

France
University Hospital, Brest

Unknown

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure (FIT-H)

Venous Thromboembolic Disease

France
Qianfoshan Hospital

Not yet recruiting

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

Venous Thromboembolic Disease

China
ThromboGenics
BioInvent International AB

Completed

Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery

Prophylaxis of Venous Thromboembolic Events

Austria, Netherlands, Belgium, Bulgaria, Hungary, Latvia, Poland, Russian Federation, Ukraine
Centre Hospitalier Universitaire de Saint Etienne

Completed

Predictors of Attempted Inferior Vena Cava Filters Retrieval.

Venous Thromboembolic Disease

France
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Atrial Fibrillation | Arterial Thromboembolic Events

United States
Hawler Medical University

Completed

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Venous Thromboembolic Diseases

Iraq
Bayer

Completed

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Atrial Fibrillation | Prevention of Thromboembolic Events

United States
University Hospital, Strasbourg, France

Unknown

Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study

Venous Thromboembolic Disease

France
University Hospital, Strasbourg, France

Unknown

Observational Prospectif Monocentric Registry of Patients Suffering From VIE (REMOTEV)

Venous Thromboembolic Disease

France
GlaxoSmithKline

Completed

CV Events in Emetogenic Chemotherapy

Vomiting | Cardiovascular Event | Arterial Thromboembolic Event
Odense University Hospital

Completed

The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study) (PETVET)

Venous Thromboembolic Disease

Denmark
Centre Hospitalier Eure-Seine

Not yet recruiting

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk (TEVEDOM)

Thromboembolic Disease
DSM Nutritional Products, Inc.

Completed

Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device

Thromboembolic Events

Germany, United States, Switzerland
Amsterdam UMC, location VUmc
Trombosestichting Nederland

Recruiting

BPA in CTEPD Without PH (BALLOON)

Chronic Thromboembolic Disease

Netherlands
University of Colorado, Denver
Bayer

Recruiting

Treatment of Exercise-Induced Pulmonary Vascular Dysfunction in Symptomatic Patients After Pulmonary Thromboendarterectomy

Chronic Thromboembolic Disease (CTED) | Exercise Intolerance Post PEA Surgery

United States
Central Hospital, Nancy, France

Completed

Safety of Direct Oral Anticoagulant During Pregnancy (SACOD)

Thromboembolic Disease

France
Centre Hospitalier Sud Francilien

Completed

Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period (THROM-PP2021)

Thromboembolic Disease

France
Bayer
Janssen Research & Development, LLC

Completed

A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants

Thromboembolic Disorders

Germany
Ottawa Hospital Research Institute

Completed

Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) (PREDICTORS)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboembolic Disease Recurrent | Recurrent Thromboembolic Disease

Canada, Netherlands, Switzerland
Second Affiliated Hospital of Wenzhou Medical University

Unknown

An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery

Thromboembolic Disease | Gynecological Surgery

China
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets (BAT-VTE)

Venous Thromboembolic Disease

France
CSL Behring
Kaiser Permanente

Completed

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Hemorrhage

United States
Les Laboratoires des Médicaments Stériles

Completed

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® (ENOXACARE)

Gastrointestinal Neoplasms | Thromboembolic Event

Tunisia
Institut de Cancérologie de la Loire
Centre Hospitalier Universitaire de Saint Etienne; CH Roanne

Completed

Radiation Impact on Thromboembolic Events (RIT)

Malignant Neoplasm

France
AstraZeneca

Terminated

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events (EXTEND)

Thromboembolism

Sweden, France, Mexico, Poland, South Africa, Spain, Germany, Hungary, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Switzerland
University of California, San Francisco

Recruiting

Chronic Thromboembolic Disease Registry

Chronic Thromboembolic Pulmonary Hypertension | Chronic Thromboembolic Disease

United States
Institut Cancerologie de l'Ouest
Diagnostica Stago

Recruiting

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk (THROMBIN)

Solid Carcinoma

France
TeaRx LLC

Completed

Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement

Total Knee Replacement

Russian Federation
C. R. Bard

Completed

Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. (EVEREST)

Pulmonary Embolism | Venous Thromboembolic Disease
Sanofi

Completed

Enoxaparin in Acute Venous Thromboembolic Disease

Venous Thrombosis

Turkey
ThromboGenics
Covance; BioInvent International AB

Completed

Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

Total Knee Replacement Surgery

Israel, Romania, Bulgaria, Latvia, Poland, Russian Federation, Ukraine
Bayer

Completed

Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")

Prevention of Thromboembolic Events

Germany
Georgetown University
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia (PROTECT DC)

Stroke

United States
Pfizer

Completed

S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation (SIFA)

Atrial Fibrillation

Italy
Institut universitaire de cardiologie et de pneumologie...

Not yet recruiting

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study (RE-DRT)

Thromboembolic Event | Percutaneous Left Atrial Appendage Occlusion (LAAO) | Device-related Thrombus (DRT) | Major Cardioembolic Events | Major Bleeding - TIMI Classification
University of California, Los Angeles

Completed

Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry (RAPID)

Pulmonary Embolism | Deep Venous Thrombosis | Venous Thromboembolic Disease | Right Heart Pathology
ARYx Therapeutics

Unknown

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation (EmbraceAC)

Myocardial Infarction | Atrial Fibrillation | Atrial Flutter | Cardiomyopathy | Venous Thromboembolic Disease

United States
Rigshospitalet, Denmark

Completed

Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty. (FETA)

Thromboembolic Events | Post-operative Bleeding

Denmark
China-Japan Friendship Hospital

Not yet recruiting

CHIPs-VTE Study in Hospitalized Patients With Lung Cancer

Pulmonary Embolism | Deep Venous Thrombosis | Venous Thromboembolic Disease
University of Sheffield
Sheffield Teaching Hospitals NHS Foundation Trust

Unknown

Iodine Subtraction Mapping in the Diagnosis of Chronic Pulmonary Thromboembolic Disease (INSPIRE)

Chronic Thromboembolic Pulmonary Hypertension
Uppsala University

Completed

RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients (REBUS)

Myocardial Infarction

Sweden
Texas Cardiac Arrhythmia Research Foundation

Unknown

Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation (GSAF)

Thromboembolic Events

United States
Sanofi

Terminated

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation (BOREALIS-AF)

Atrial Fibrillation

South Africa, Thailand, Chile, Guatemala, Ukraine, United States, Argentina, Australia, Austria, Belarus, Brazil, Bulgaria, Canada, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Greece, India, ... and more
Floralis
University Hospital, Grenoble

Completed

Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports Resort (M2M-Thrombose)

Leg Injuries | Outpatients | Winter Sport Resorts

France
University of Aarhus
Hospitalsenheden Vest

Unknown

Symptom-driven Referral for Evaluation of Chronic Thromboembolic Disease or Pulmonary Hypertension in Patients With Previous Acute Pulmonary Embolism

Chronic Thromboembolic Pulmonary Disease

Clinical Trials on Thromboembolic Pathology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations